Crinetics Pharmaceuticals (CRNX)

• Market cap: $4.56B
• 1 day: 1.67%
• 5 days: 1.92%
• 1 month: -15.23%
• 3 months: 1.55%
• 6 months: 47.96%
• Year to date: -4.73%
• 1 year: 28.6%
• 5 years: 184.11%
• 10 years: 81.64%
• Sector: Healthcare
• Industry: Biotechnology

About: Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Employees: 437